BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zou ZM, Chang DH, Liu H, Xiao YD. Current updates in machine learning in the prediction of therapeutic outcome of hepatocellular carcinoma: what should we know? Insights Imaging 2021;12:31. [PMID: 33675433 DOI: 10.1186/s13244-021-00977-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Blidisel A, Marcovici I, Coricovac D, Hut F, Dehelean CA, Cretu OM. Experimental Models of Hepatocellular Carcinoma-A Preclinical Perspective. Cancers (Basel) 2021;13:3651. [PMID: 34359553 DOI: 10.3390/cancers13153651] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Tan J, Mathy RM, Chang DH, Tang T, Zhang ZS, Xiao YD. Combined transarterial iodized oil injection and computed tomography-guided thermal ablation for hepatocellular carcinoma: utility of the iodized oil retention pattern. Abdom Radiol (NY) 2021. [PMID: 34642785 DOI: 10.1007/s00261-021-03305-3] [Reference Citation Analysis]
3 Wong GL, Hui VW, Tan Q, Xu J, Lee HW, Yip TC, Yang B, Tse Y, Yin C, Lyu F, Lai JC, Lui GC, Chan HL, Yuen P, Wong VW. Novel machine-learning models outperform risk scores in predicting hepatocellular carcinoma in patients with chronic viral hepatitis. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100441] [Reference Citation Analysis]
4 Zou ZM, An TZ, Li JX, Zhang ZS, Xiao YD, Liu J. Predicting early refractoriness of transarterial chemoembolization in patients with hepatocellular carcinoma using a random forest algorithm: A pilot study. J Cancer 2021;12:7079-87. [PMID: 34729109 DOI: 10.7150/jca.63370] [Reference Citation Analysis]
5 Zhou H, Jiang T, Li Q, Zhang C, Zhang C, Liu Y, Cao J, Sun Y, Jin P, Luo J, Pan M, Huang P. US-Based Deep Learning Model for Differentiating Hepatocellular Carcinoma (HCC) From Other Malignancy in Cirrhotic Patients. Front Oncol 2021;11:672055. [PMID: 34168992 DOI: 10.3389/fonc.2021.672055] [Reference Citation Analysis]
6 Yang XY, Deng JB, An TZ, Zhou S, Li JX. Tumor enhancement ratio with unenhanced imaging is an independent prognostic factor for patients with hepatocellular carcinoma after transarterial chemoembolization. J Int Med Res 2021;49:3000605211058367. [PMID: 34812068 DOI: 10.1177/03000605211058367] [Reference Citation Analysis]